{
  "ticker": "REGN",
  "year": 2023,
  "quarter": 3,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 30,
  "transactions": [
    {
      "id": 160232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-08",
      "transaction_shares": "240",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "240"
    },
    {
      "id": 160265,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-08",
      "transaction_shares": "240",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "240"
    },
    {
      "id": 214426,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-08",
      "transaction_shares": "240",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "240"
    },
    {
      "id": 214477,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-08",
      "transaction_shares": "240",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "240"
    },
    {
      "id": 160247,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-09-01",
      "transaction_shares": "250",
      "transaction_price": "834.55",
      "transaction_type": "S",
      "shares_after_transaction": "19803"
    },
    {
      "id": 214449,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-09-01",
      "transaction_shares": "250",
      "transaction_price": "834.55",
      "transaction_type": "S",
      "shares_after_transaction": "19803"
    },
    {
      "id": 160170,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-08-23",
      "transaction_shares": "7000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "26140"
    },
    {
      "id": 160216,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-08-23",
      "transaction_shares": "223",
      "transaction_price": "844.0",
      "transaction_type": "S",
      "shares_after_transaction": "31699"
    },
    {
      "id": 160230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2023-08-23",
      "transaction_shares": "23125",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "44633"
    },
    {
      "id": 160259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-23",
      "transaction_shares": "12280",
      "transaction_price": "273.67",
      "transaction_type": "M",
      "shares_after_transaction": "14317"
    },
    {
      "id": 214342,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-08-23",
      "transaction_shares": "7000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "26140"
    },
    {
      "id": 214405,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-08-23",
      "transaction_shares": "223",
      "transaction_price": "844.0",
      "transaction_type": "S",
      "shares_after_transaction": "31699"
    },
    {
      "id": 214423,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2023-08-23",
      "transaction_shares": "23125",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "44633"
    },
    {
      "id": 214470,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-23",
      "transaction_shares": "12280",
      "transaction_price": "273.67",
      "transaction_type": "M",
      "shares_after_transaction": "14317"
    },
    {
      "id": 160194,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2023-08-21",
      "transaction_shares": "50000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "103100"
    },
    {
      "id": 160198,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-21",
      "transaction_shares": "853",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2100"
    },
    {
      "id": 214379,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2023-08-21",
      "transaction_shares": "50000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "103100"
    },
    {
      "id": 214383,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-21",
      "transaction_shares": "853",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2100"
    },
    {
      "id": 160202,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "853",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2100"
    },
    {
      "id": 214387,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "853",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2100"
    },
    {
      "id": 160233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-08-01",
      "transaction_shares": "250",
      "transaction_price": "744.66",
      "transaction_type": "S",
      "shares_after_transaction": "20053"
    },
    {
      "id": 160270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-01",
      "transaction_shares": "2",
      "transaction_price": "732.76",
      "transaction_type": "S",
      "shares_after_transaction": "18745"
    },
    {
      "id": 214427,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-08-01",
      "transaction_shares": "250",
      "transaction_price": "744.66",
      "transaction_type": "S",
      "shares_after_transaction": "20053"
    },
    {
      "id": 214482,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-01",
      "transaction_shares": "2",
      "transaction_price": "732.76",
      "transaction_type": "S",
      "shares_after_transaction": "18745"
    },
    {
      "id": 113208,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "1",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "18846"
    },
    {
      "id": 113240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-07-03",
      "transaction_shares": "250",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "20303"
    },
    {
      "id": 160214,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "1",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "18846"
    },
    {
      "id": 160251,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-07-03",
      "transaction_shares": "250",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "20303"
    },
    {
      "id": 214402,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-03",
      "transaction_shares": "1",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "18846"
    },
    {
      "id": 214453,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-07-03",
      "transaction_shares": "250",
      "transaction_price": "710.09",
      "transaction_type": "S",
      "shares_after_transaction": "20303"
    }
  ]
}